Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)
Clinical trial NCT04084080 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04084080
- Sponsor
- University of Pittsburgh
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-26
- Primary completion
- 2026-07-31
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.